Sverre Langorgen
St. Olavs Hospital
Trondheim, Norway
Trondheim, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Added Value of [18F]PSMA-1007 PET/CT and PET/MRI in Patients With Biochemically Recurrent Prostate Cancer: Impact on Detection Rates and Clinical Management.
Journal: Journal of magnetic resonance imaging : JMRI
Published: July 04, 2023
En bloc radical cystectomy: An overview of the technique and oncological results.
Journal: BJUI compass
Published: May 05, 2022
Pseudo-T2 mapping for normalization of T2-weighted prostate MRI.
Journal: Magma (New York, N.Y.)
Published: September 24, 2021
The Reproducibility of Deep Learning-Based Segmentation of the Prostate Gland and Zones on T2-Weighted MR Images.
Journal: Diagnostics (Basel, Switzerland)
Published: August 10, 2021
Detection of Recurrent Prostate Cancer With 18F-Fluciclovine PET/MRI.
Journal: Frontiers in oncology
Published: July 10, 2020
Relative Enhanced Diffusivity in Prostate Cancer: Protocol Optimization and Diagnostic Potential.
Journal: Journal of magnetic resonance imaging : JMRI
Published: September 20, 2019
Prostate-Specific Membrane Antigen PET/Magnetic Resonance Imaging for the Planning of Salvage Radiotherapy in Patients with Prostate Cancer with Biochemical Recurrence After Radical Prostatectomy.
Journal: PET clinics
Published: September 02, 2019
18F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients.
Journal: European radiology
Published: July 13, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026